1. Burrows, F.A., J. Lerman, K.M. Ledez and H.A. Strong. Pharmacokinetics of Lidocaine in children with congenital heart disease. Canadian Journal of Anaesthesia 38:196-200, 1991.
  2. Canafax, D.M. and G.S. Giebink. Clinical and pharmacokinetic basis for the antimicrobial treatment of acute otitis media. Otolaryngologic Clinics of North America 24:859-875, 1991.
  3. Chan, G.L. and E.E. Hodge. Effect of plasmapheresis on cyclosporine pharmacokinetics. DICP-The Annals of Pharmacotherapy 25:211-211, 1991.
  4. Colino, C.I., C.F. Lastra, F.G. Lopez, A. Ledesma and E.L. Marino. Open-loop feedback-control of serum bentazepam concentrations and Bayesian-estimation in multiple dosage regimens in patients. International Journal of Clinical Pharmacology Therapy and Toxicology 29:457-462, 1991.
  5. Conley, B.A., G.F. Sewack, M.J. Egorin, B. Subramanyam, J.G. Page and C.K. Grieshaber. The effect of the monoamine oxidase inhibitor Isocarboxazid on the canine metabolism of the cell differentiating agent hexamethylene bisacetamide. Cancer Chemotherapy and Pharmacology 28:33-38, 1991.
  6. Derewlany, L.O., J.S. Leeder, R. Kumar, I.C. Radde, B. Knie and G. Koren. The transport of Digoxin across the perfused human placental lobule. Journal of Pharmacology and Experimental Therapeutics 256:1107-1111, 1991.
  7. Devaleriola, D.L., D.D. Ross, A. Forrest, D.P. Cuddy and M.J. Egorin. Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs. Cancer Chemotherapy and Pharmacology 29:133-140, 1991.
  8. Dodion, P.F., D. Devaleriola, N. Crespeigne, J.D. Kantrowitz, M. Piccart, F. Wery, J. Kerger, M.J. Egorin, A. Forrest, N.R. Bachur, P. Alaerts, A. Carver, R. Rastogi, L. Hammershaimb and S. Saletan. Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex. Annals of Oncology 2:589-596, 1991.
  9. Drusano, G.L. Optimal sampling theory and population modeling application to determination of the influence of the microgravity environment on drug distribution and elimination. Journal of Clinical Pharmacology 31:962-967, 1991.
  10. Eltahtawy, A. and W. Wolf. In vivo measurements of intratumoral metabolism, modulation, and pharmacokinetics of 5-Fluorouracil, using F-19 nuclear magnetic resonance spectroscopy. Cancer Research 51:5806-5812, 1991.
  11. Englund, J.A., C.V. Fletcher and H.H. Balfour. Acyclovir therapy in neonates. Journal of Pediatrics 119:129-135, 1991.
  12. Errecalde, J.O., C.E. Lanusse, O.N. Mestorino, M.F. Landoni and A.L. Soraci. Pharmacokinetics of Ticarcillin and Ticarcillin-probenecid in sheep. Journal of Veterinary Medicine Series A 38:255-260, 1991.
  13. Ferrazzini, G., H. Sohl, I. Robieux, D. Johnson, E. Giesbrecht and G. Koren. Diurnal variation of methotrexate disposition in children with acute leukemia. European Journal of Clinical Pharmacology 41:425-427, 1991.
  14. Fletcher, C.V., J.A. Englund, C.K. Edelman, C.R. Gross, D.L. Dunn and H.H. Balfour. Pharmacological basis for high dose oral Acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients. Antimicrobial Agents and Chemotherapy 35:938-943, 1991.
  15. Fontana, J.A., A. Burrowsmezu, D.R. Clemmons and D. Leroith. Retinoid modulation of insulin like growth factor binding proteins and inhibition of breast carcinoma proliferation. Endocrinology 128:1115-1122, 1991.
  16. Friedrich, L.V., R.L.White, M.B. Kays, D.M. Brundage and D. Yarbrough. Aztreonam pharmacokinetics in burn patients. Antimicrobial Agents and Chemotherapy 35:57-61, 1991.
  17. Hernandez-Rivas, P., C.F. Lastra, F.G. Lopez, J.A. Gonzalez, J. Domenech and E.L. Marino. Adaptive and Bayesian control of Digoxin in geriatric patients. European Journal of Drug Metabolism and Pharmacokinetic 3:332-337, 1991.
  18. Ko, R.J., F.R. Sattler, S. Nichols, E. Akriviadis, B. Runyon, M. Appleman, J.L. Cohen and R.T. Koda. Pharmacokinetics of Cefotaxime and Desacetylcefotaxime in patients with liver disease. Antimicrobial Agents and Chemotherapy 35:1376-1380, 1991.
  19. Matsui, D., J. Klein, C. Hermann, V. Grunau, R. McClelland, D. Chung, P. Stlouis, N. Olivieri and G. Koren. Relationship between the pharmacokinetics and iron excretion pharmacodynamics of the new oral iron chelator 1,2-Dimethyl-3-Hydroxypyrid-4-one in patients with thalassemia. Clinical Pharmacology and Therapeutics 50:294-298, 1991.
  20. McLeod, H.L., D.K. Baker, C.H. Pui and J.H. Rodman. Somnolence, Hypotension, and metabolic acidosis following high dose teniposide treatment. Cancer Chemotherapy and Pharmacology 29:150-154, 1991.
  21. Nokta, M., J.P. Loh, S.M. Douidar, A.E. Ahmed and R.B. Pollard. Metabolic interaction of recombinant interferon beta and Zidovudine in AIDS patients. Journal of Interferon Research 11:159-164, 1991.
  22. Ratain, M.J., R. Mick, R.L. Schilsky, N.J. Vogelzang and F. Berezin. Pharmacologically based dosing of Etoposide – a means of safely increasing dose intensity. Journal of Clinical Oncology 9:1480-1486, 1991.
  23. Trump, D.L., M.J. Egorin, A. Forrest, J.K.V. Willson, S. Remick and K.D. Tutsch. Pharmacokinetic and pharmacodynamic analysis of Fluorouracil during 72-hour continuous infusion with and without Dipyridamole. Journal of Clinical Oncology 9:2027- 2035, 1991.
  24. Urbaitis, B.K., A. Razynska, Q. Corteza, C. Fronticelli and E. Bucci. Intravascular retention and renal handling of purified natural and intramolecularly cross linked hemoglobins. Journal of Laboratory and Clinical Medicine 117:115-121, 1991.
  25. Wiest, D.B., B.L. Ohning and S.S. Garner. The disposition of Alfentanil in neonates with respiratory distress. Pharmacotherapy 11:308-311, 1991.
  26. Wiest, D.B., D.L. Trippel, P.C. Gillette and S.S. Garner. Pharmacokinetics of Esmolol in children. Clinical Pharmacology and Therapeutics 49:618-623, 1991.
  27. Woodworth, J.R., A.F. Delong, A.F. Fasola and S. Oldham. Isomazole disposition in man as a function of dose and route of administration. Biopharmaceutics and Drug Disposition 12:673-686, 1991.